Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Anais Ventures
LancySeries A–Series C
3 people
Companion Fund
New YorkPre-Seed–Growth
JAFCO Asia
SingaporeSeed–Late Stage
9 people
X-Ventures Venture Fund Management Company
BudapestSeries A–Series B
GrainCorp Ventures
SydneySeed–Series B$500K – $4M
1 person
Xerys
ParisSeed–Late Stage$16M – $97M
1 person
Syngenta Group Ventures
DurhamSeed–Growth$500K – $5M
6 people
Zen11 Holding
GrazSeries A–Growth
EDB Investments
SingaporeSeed–Late Stage
11 people
NGN Capital
New YorkSeries A–Late Stage
5 people
NYVC Ventures
New YorkPre-Seed–Series B
5 people
WONIK Investment Partners
SeoulSeries A–Late Stage
11 people
Brama One Ventures
SurabayaSeed–Growth
2 people
Manta International Consultancy S.A.L
Seed–Series C
2 people
Elevat3 Capital
VallettaSeed–Growth$5M – $20M
1 person
Black Marble Capital Management
TaipeiSeed–Late Stage
12 people
Diamond Biofund
TaipeiSeed–Series B
6 people
Empire State Development – New York Ventures
New YorkPre-Seed–Series B$500K – $1.5M
9 people
Bluebird Ventures
Palo AltoSeed–Series B
1 person
Dynamk Capital
New YorkSeed–Series B
4 people
Health Technology Holding (HTH)
Pre-Seed–Series B$500K – $1M
2 people
Thuja Capital
UtrechtSeed–Series B
7 people
Abbhi Capital
MiamiSeed–Late Stage
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.

















































